The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $122.57

Today's change+0.93 +0.76%
Updated May 22 4:15 PM EDT. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $122.57

Today's change+0.93 +0.76%
Updated May 22 4:15 PM EDT. Delayed by at least 15 minutes.

United Therapeutics Corp crosses above 20-day moving average

United Therapeutics Corp closed up Monday by (U.S.)$0.93 or 0.76% to (U.S.)$122.57 and crossing above its 20-day moving average. Over the last five days, shares have lost 0.40% and are down 14.54% for the last year to date. This security has underperformed the S&P 500 by 8.77% during the last year.

Key company metrics

  • Open(U.S.) $122.31
  • Previous close(U.S.) $121.64
  • High(U.S.) $123.50
  • Low(U.S.) $121.17
  • Bid / Ask(U.S.) $101.21 / (U.S.) $0.00
  • YTD % change-14.54%
  • Volume375,132
  • Average volume (10-day)469,134
  • Average volume (1-month)594,978
  • Average volume (3-month)628,166
  • 52-week range(U.S.) $97.52 to (U.S.) $169.89
  • Beta1.57
  • Trailing P/E8.62×
  • P/E 1 year forward8.41×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $14.22
Updated May 22 4:15 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.19%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue371409408413
Total other revenue--------
Total revenue371409408413
Gross profit356381385393
Total cost of revenue14282420
Total operating expense107235170127
Selling / general / administrative5614010072
Research & development36674635
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income264174239285
Interest income (expense), net non-operating-1-2-1-1
Gain (loss) on sale of assets--00--
Other--------
Income before tax264172239286
Income after tax179110162206
Income tax, total85617780
Net income179110162206
Total adjustments to net income--------
Net income before extra. items179110162206
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items179110162206
Inc. avail. to common incl. extra. items179110162206
Diluted net income179110162206
Dilution adjustment--------
Diluted weighted average shares46454647
Diluted EPS excluding extraordinary itemsvalue per share3.892.433.504.39
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share3.892.433.504.39